Clinical Trial Update: Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating zoledronic acid, pravastatin, and lonafarnib for patients with Progeria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progeria

Drugs mentioned

• Lonafarnib (lonafarnib)
• Pravastatin (pravastatin)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Progeria | Phase 2 | Status: UNKNOWN